Insider · CIK 0001799363

Lin Patrick

Reports to the SEC for 1 company · VERO BEACH, FL

sec.gov

Transactions

Companies

Filings

CIK

0001799363

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-07-26	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+8,450 sh	—	—	11,389
2026-06-30	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+2,106 sh	$1.93	+$4,064.58	13,113
2026-06-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+1,831 sh	$2.22	+$4,064.82	11,007
2026-05-29	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+1,582 sh	$2.57	+$4,065.74	9,176
2026-05-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+1,369 sh	$2.97	+$4,065.93	7,594
2026-04-30	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+1,511 sh	$2.69	+$4,064.59	6,236
2026-04-15	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+1,369 sh	$2.97	+$4,065.93	4,725
2026-03-31	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+1,603 sh	$2.54	+$4,063.605	3,356
2026-01-01	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business - Strategy Off	MExercise/Conversion	+193 sh	—	—	1,753
2026-01-01	PCSAProcessa Pharmaceuticals, Inc. · Common StockM Exercise/Conversion	Chief Business - Strategy Off	MExercise/Conversion	−193 sh	—	—	0
2025-10-01	PCSAProcessa Pharmaceuticals, Inc. · Stock Options (Right to Buy)A Award	Chief Business - Strategy Off	AAward	+204K sh	—	—	204,000
2025-10-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+68K sh	—	—	68,000
2025-07-24	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+1.4M sh	—	—	1,412,082
2025-04-01	PCSAProcessa Pharmaceuticals, Inc.F Tax Payment	Chief Business - Strategy Off	FTax Payment	−4,814 sh	$0.41	−$1,983.368	38,727
2025-04-01	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business - Strategy Off	MExercise/Conversion	+14.5K sh	—	—	43,541
2025-01-29	PCSAProcessa Pharmaceuticals, Inc. · WarrantsA Award	Chief Business - Strategy Off	AAward	+43.5K sh	—	—	43,500
2025-01-29	PCSAProcessa Pharmaceuticals, Inc. · WarrantsA Award	Chief Business - Strategy Off	AAward	+21.8K sh	—	—	21,750
2025-01-27	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+43.5K sh	$0.80	+$34.7K	43,500
2024-07-10	PCSAProcessa Pharmaceuticals, Inc.F Tax Payment	Chief Business - Strategy Off	FTax Payment	−271 sh	$1.71	−$463.41	29,059
2024-07-10	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business - Strategy Off	MExercise/Conversion	+644 sh	—	—	29,330
2024-06-28	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+339 sh	—	—	24,575
2024-06-28	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+2,713 sh	—	—	22,201
2024-06-28	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+2,035 sh	—	—	24,236
2024-06-28	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+339 sh	—	—	24,914
2024-04-05	PCSAProcessa Pharmaceuticals, Inc.F Tax Payment	Chief Business - Strategy Off	FTax Payment	−539 sh	$2.79	−$1,503.81	28,686
2024-04-05	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business - Strategy Off	MExercise/Conversion	+1,675 sh	—	—	29,225
2024-02-01	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+1,500 sh	$2.40	+$3,600	27,478
2024-01-31	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+2,500 sh	$2.37	+$5,925	25,978
2024-01-01	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business - Strategy Off	MExercise/Conversion	+1,675 sh	—	—	29,153
2024-01-01	PCSAProcessa Pharmaceuticals, Inc.F Tax Payment	Chief Business - Strategy Off	FTax Payment	−539 sh	$2.79	−$1,503.81	28,614
2024-01-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Business - Strategy Off	MExercise/Conversion	−1,675 sh	—	—	20,132
2023-10-12	PCSAProcessa Pharmaceuticals, Inc.A Award	Chief Business - Strategy Off	AAward	+5,000 sh	$0.32	+$1,600	469,535
2023-10-10	PCSAProcessa Pharmaceuticals, Inc.A Award	Chief Business - Strategy Off	AAward	+13.7K sh	$0.21	+$2,877	464,535
2023-02-09	PCSAProcessa Pharmaceuticals, Inc.A Award	Chief Business - Strategy Off	AAward	+12.5K sh	$0.80	+$10K	450,835
2023-01-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+40.7K sh	—	—	440,328
2023-01-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+55.1K sh	—	—	399,638
2022-12-31	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+10.9K sh	—	—	344,531
2022-09-30	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+10.9K sh	—	—	333,680
2022-08-05	PCSAProcessa Pharmaceuticals, Inc.F Tax Payment	Chief Business - Strategy Off	FTax Payment	−2,656 sh	$3.17	−$8,419.52	438,335
2022-08-05	PCSAProcessa Pharmaceuticals, Inc.M Exercise/Conversion	Chief Business - Strategy Off	MExercise/Conversion	+7,601 sh	—	—	440,991
2022-06-30	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+20.1K sh	—	—	322,830
2022-05-17	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+2,000 sh	$1.59	+$3,189	433,390
2022-04-07	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+800 sh	$3.54	+$2,835.04	431,390
2022-04-06	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+1,200 sh	$3.13	+$3,752.04	430,590
2022-04-01	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+248K sh	—	—	302,766
2022-03-31	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+10.7K sh	—	—	37,781
2021-12-31	PCSAProcessa Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Business - Strategy Off	AAward	+6,722 sh	—	—	22,780
2021-12-14	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+3,000 sh	$4.00	+$12K	429,390
2021-12-14	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+3,000 sh	$4.00	+$12K	429,390
2021-12-03	PCSAProcessa Pharmaceuticals, Inc.P Purchase	Chief Business - Strategy Off	PPurchase	+3,500 sh	$4.80	+$16.8K	426,390

Recent filings

Accepted (ET)
Jul 284
Lin Patrick0000897069-26-001550
SEC(opens sec.gov)
Jul 14
Lin Patrick0000897069-26-001482
SEC(opens sec.gov)
Jun 164
Lin Patrick0000897069-26-001408
SEC(opens sec.gov)
Jun 14
Lin Patrick0000897069-26-001289
SEC(opens sec.gov)
May 194
Lin Patrick0000897069-26-001182
SEC(opens sec.gov)
May 14
Lin Patrick0000897069-26-001004
SEC(opens sec.gov)
Apr 174
Lin Patrick0000897069-26-000908
SEC(opens sec.gov)
Apr 14
Lin Patrick0000897069-26-000747
SEC(opens sec.gov)
Feb 44
Lin Patrick0000897069-26-000222
SEC(opens sec.gov)
Oct 34
Lin Patrick0000897069-25-001551
SEC(opens sec.gov)
Jul 284
Lin Patrick0000897069-25-001221
SEC(opens sec.gov)
Apr 114
Lin Patrick0000897069-25-000795
SEC(opens sec.gov)
Feb 184/A
Lin Patrick0000897069-25-000292
SEC(opens sec.gov)
Jan 294
Lin Patrick0000897069-25-000130
SEC(opens sec.gov)
Aug 24
Lin Patrick0000897069-24-001611
SEC(opens sec.gov)

Companies

Processa Pharmaceuticals, Inc.Chief Business - Strategy OffPCSA

Address

C/O PROCESSA PHARMACEUTICALS, INC. 601 21ST STREET SUITE 300

VERO BEACH, FL, 32960